Cargando…
Ets-2 Acts As a Transcriptional Repressor of the Human Immunodeficiency Virus Type 1 through Binding to a Repressor–Activator Target Sequence of 5′-LTR
HIV-1 is transcriptionally active in activated T helper (Th)-cells and inactive in naive or resting memory Th-cells. Ets-2 is a preinduction transcriptional repressor of the IL-2 gene in naive Th-cells and a candidate transcriptional repressor of HIV-1 in the same cells, because the −279 to −250 ups...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758550/ https://www.ncbi.nlm.nih.gov/pubmed/29354130 http://dx.doi.org/10.3389/fimmu.2017.01924 |
_version_ | 1783291011706912768 |
---|---|
author | Panagoulias, Ioannis Karagiannis, Fotios Aggeletopoulou, Ioanna Georgakopoulos, Tassos Argyropoulos, Christos P. Akinosoglou, Karolina Gogos, Charalambos Skoutelis, Athanasios Mouzaki, Athanasia |
author_facet | Panagoulias, Ioannis Karagiannis, Fotios Aggeletopoulou, Ioanna Georgakopoulos, Tassos Argyropoulos, Christos P. Akinosoglou, Karolina Gogos, Charalambos Skoutelis, Athanasios Mouzaki, Athanasia |
author_sort | Panagoulias, Ioannis |
collection | PubMed |
description | HIV-1 is transcriptionally active in activated T helper (Th)-cells and inactive in naive or resting memory Th-cells. Ets-2 is a preinduction transcriptional repressor of the IL-2 gene in naive Th-cells and a candidate transcriptional repressor of HIV-1 in the same cells, because the −279 to −250 upstream region of HIV-1-LTR [repressor–activator target sequence (RATS)], that participates in HIV-1-LTR transcriptional silencing, encompasses the AAGGAG Ets-2 binding site. In this proof of concept study, we investigated whether Ets-2 represses the expression of HIV-1. To assess whether Ets-2 can repress HIV-1 transcriptional activation acting through RATS, we transfected Jurkat cells with an Ets-2 overexpression plasmid (pCDNA3-ets-2) or Ets-2 silencing plasmids (ets-2-shRNA) and, as target genes, plasmids carrying the whole HIV-1-LTR sequence (HIV-1-LTR-CAT) or two copies of the RATS sequence (2× RATS-CAT) or a point mutation in the Ets-2 binding site (2× mutantRATS-CAT) or CMV-CAT (control). Ets-2 overexpression resulted in a significant reduction of HIV-1-LTR-CAT and 2× RATS-CAT activities in stimulated cells, but not of the 2× mutantRATS-CAT or CMV-CAT. Ets-2 silencing led to increased activities of HIV-1-LTR-CAT and 2× RATS-CAT in unstimulated cells, but had no effect on the activities of 2× mutantRATS-CAT and CMV-CAT. To assess Ets-2 binding to HIV-1-LTR–RATS in naive Th-cells, we isolated naive Th-cell nuclear proteins and passed them through an Ets-2 antibody column; electrophoretic mobility shift assays were performed using an RATS probe mixed with consecutive protein eluates. Ets-2 bound to the HIV-1-LTR–RATS in a dose-dependent manner. To assess Ets-2 binding to RATS in vivo, Jurkat cells were transfected with 2× RATS-CAT and stained for the Ets-2 protein and the RATS sequence by combining immunofluorescence and fluorescence in situ hybridization techniques. In unstimulated cells, Ets-2 bound to RATS, whereas no binding was observed in stimulated cells. To test for RATS specificity, the same experiments were performed with 2× mutantRATS-CAT, and no binding of Ets-2 was observed. The results were corroborated by chromatin immunoprecipitation assays performed with the same cells. Our results show that Ets-2 is a transcriptional repressor of HIV-1. Repression of HIV-LTR-RATS mediated by Ets-2 may account for the low-level transcription and replication of HIV-1 in naive Th-cells, and contribute to the viral latency and maintenance of viral reservoirs in patients, despite long-term therapy. |
format | Online Article Text |
id | pubmed-5758550 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-57585502018-01-19 Ets-2 Acts As a Transcriptional Repressor of the Human Immunodeficiency Virus Type 1 through Binding to a Repressor–Activator Target Sequence of 5′-LTR Panagoulias, Ioannis Karagiannis, Fotios Aggeletopoulou, Ioanna Georgakopoulos, Tassos Argyropoulos, Christos P. Akinosoglou, Karolina Gogos, Charalambos Skoutelis, Athanasios Mouzaki, Athanasia Front Immunol Immunology HIV-1 is transcriptionally active in activated T helper (Th)-cells and inactive in naive or resting memory Th-cells. Ets-2 is a preinduction transcriptional repressor of the IL-2 gene in naive Th-cells and a candidate transcriptional repressor of HIV-1 in the same cells, because the −279 to −250 upstream region of HIV-1-LTR [repressor–activator target sequence (RATS)], that participates in HIV-1-LTR transcriptional silencing, encompasses the AAGGAG Ets-2 binding site. In this proof of concept study, we investigated whether Ets-2 represses the expression of HIV-1. To assess whether Ets-2 can repress HIV-1 transcriptional activation acting through RATS, we transfected Jurkat cells with an Ets-2 overexpression plasmid (pCDNA3-ets-2) or Ets-2 silencing plasmids (ets-2-shRNA) and, as target genes, plasmids carrying the whole HIV-1-LTR sequence (HIV-1-LTR-CAT) or two copies of the RATS sequence (2× RATS-CAT) or a point mutation in the Ets-2 binding site (2× mutantRATS-CAT) or CMV-CAT (control). Ets-2 overexpression resulted in a significant reduction of HIV-1-LTR-CAT and 2× RATS-CAT activities in stimulated cells, but not of the 2× mutantRATS-CAT or CMV-CAT. Ets-2 silencing led to increased activities of HIV-1-LTR-CAT and 2× RATS-CAT in unstimulated cells, but had no effect on the activities of 2× mutantRATS-CAT and CMV-CAT. To assess Ets-2 binding to HIV-1-LTR–RATS in naive Th-cells, we isolated naive Th-cell nuclear proteins and passed them through an Ets-2 antibody column; electrophoretic mobility shift assays were performed using an RATS probe mixed with consecutive protein eluates. Ets-2 bound to the HIV-1-LTR–RATS in a dose-dependent manner. To assess Ets-2 binding to RATS in vivo, Jurkat cells were transfected with 2× RATS-CAT and stained for the Ets-2 protein and the RATS sequence by combining immunofluorescence and fluorescence in situ hybridization techniques. In unstimulated cells, Ets-2 bound to RATS, whereas no binding was observed in stimulated cells. To test for RATS specificity, the same experiments were performed with 2× mutantRATS-CAT, and no binding of Ets-2 was observed. The results were corroborated by chromatin immunoprecipitation assays performed with the same cells. Our results show that Ets-2 is a transcriptional repressor of HIV-1. Repression of HIV-LTR-RATS mediated by Ets-2 may account for the low-level transcription and replication of HIV-1 in naive Th-cells, and contribute to the viral latency and maintenance of viral reservoirs in patients, despite long-term therapy. Frontiers Media S.A. 2018-01-04 /pmc/articles/PMC5758550/ /pubmed/29354130 http://dx.doi.org/10.3389/fimmu.2017.01924 Text en Copyright © 2018 Panagoulias, Karagiannis, Aggeletopoulou, Georgakopoulos, Argyropoulos, Akinosoglou, Gogos, Skoutelis and Mouzaki. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Panagoulias, Ioannis Karagiannis, Fotios Aggeletopoulou, Ioanna Georgakopoulos, Tassos Argyropoulos, Christos P. Akinosoglou, Karolina Gogos, Charalambos Skoutelis, Athanasios Mouzaki, Athanasia Ets-2 Acts As a Transcriptional Repressor of the Human Immunodeficiency Virus Type 1 through Binding to a Repressor–Activator Target Sequence of 5′-LTR |
title | Ets-2 Acts As a Transcriptional Repressor of the Human Immunodeficiency Virus Type 1 through Binding to a Repressor–Activator Target Sequence of 5′-LTR |
title_full | Ets-2 Acts As a Transcriptional Repressor of the Human Immunodeficiency Virus Type 1 through Binding to a Repressor–Activator Target Sequence of 5′-LTR |
title_fullStr | Ets-2 Acts As a Transcriptional Repressor of the Human Immunodeficiency Virus Type 1 through Binding to a Repressor–Activator Target Sequence of 5′-LTR |
title_full_unstemmed | Ets-2 Acts As a Transcriptional Repressor of the Human Immunodeficiency Virus Type 1 through Binding to a Repressor–Activator Target Sequence of 5′-LTR |
title_short | Ets-2 Acts As a Transcriptional Repressor of the Human Immunodeficiency Virus Type 1 through Binding to a Repressor–Activator Target Sequence of 5′-LTR |
title_sort | ets-2 acts as a transcriptional repressor of the human immunodeficiency virus type 1 through binding to a repressor–activator target sequence of 5′-ltr |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758550/ https://www.ncbi.nlm.nih.gov/pubmed/29354130 http://dx.doi.org/10.3389/fimmu.2017.01924 |
work_keys_str_mv | AT panagouliasioannis ets2actsasatranscriptionalrepressorofthehumanimmunodeficiencyvirustype1throughbindingtoarepressoractivatortargetsequenceof5ltr AT karagiannisfotios ets2actsasatranscriptionalrepressorofthehumanimmunodeficiencyvirustype1throughbindingtoarepressoractivatortargetsequenceof5ltr AT aggeletopoulouioanna ets2actsasatranscriptionalrepressorofthehumanimmunodeficiencyvirustype1throughbindingtoarepressoractivatortargetsequenceof5ltr AT georgakopoulostassos ets2actsasatranscriptionalrepressorofthehumanimmunodeficiencyvirustype1throughbindingtoarepressoractivatortargetsequenceof5ltr AT argyropouloschristosp ets2actsasatranscriptionalrepressorofthehumanimmunodeficiencyvirustype1throughbindingtoarepressoractivatortargetsequenceof5ltr AT akinosogloukarolina ets2actsasatranscriptionalrepressorofthehumanimmunodeficiencyvirustype1throughbindingtoarepressoractivatortargetsequenceof5ltr AT gogoscharalambos ets2actsasatranscriptionalrepressorofthehumanimmunodeficiencyvirustype1throughbindingtoarepressoractivatortargetsequenceof5ltr AT skoutelisathanasios ets2actsasatranscriptionalrepressorofthehumanimmunodeficiencyvirustype1throughbindingtoarepressoractivatortargetsequenceof5ltr AT mouzakiathanasia ets2actsasatranscriptionalrepressorofthehumanimmunodeficiencyvirustype1throughbindingtoarepressoractivatortargetsequenceof5ltr |